STOCK TITAN
  1. Home
  2. Sec-filings
  3. INVX
  4. [Form 4] Innovex International, Inc. Insider Trading Activity

Innovex International (INVX) insider funds net-sell 4.95M shares in secondary

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Innovex International, Inc. (INVX) had multiple affiliated investment funds report trades in its common stock. On 2026-08-10, funds associated with Amberjack Capital and Intervale Capital reported an aggregate net sale of 4,954,467 shares of common stock at $28.71 per share in an underwritten secondary offering to Barclays Capital Inc. One fund, Intervale Capital Fund III, L.P., is reported as acquiring 45,533 shares at the same price. These positions are held indirectly through various limited partnerships and general partners, which exercise voting and dispositive power over the shares. Following the transactions, Amberjack Capital Fund II, L.P. held 13,164,573 shares and Innovex Co-Invest Fund II, L.P. held 3,073,822 shares indirectly.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider INNOVEX CO-INVEST FUND, L.P., Innovex Co-Invest Fund GP, L.P., Interval Capital Associates II, LLC, Intervale Capital Associates III, LLC, Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., Intervale Capital Fund III, L.P., Intervale Capital GP II, L.P., Intervale Capital GP III, L.P.
Role Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner
Sold 5,000,000 shs ($143.55M)
Type Security Shares Price Value
Sale Common Stock F1, F7, F8, F9, F10 3,706,801 $28.71 $106.42M
Sale Common Stock F2, F7, F8, F9, F10 865,508 $28.71 $24.85M
Sale Common Stock F3, F7, F8, F9, F10 205,126 $28.71 $5.89M
Sale Common Stock F4, F7, F8, F9, F10 176,944 $28.71 $5.08M
Sale Common Stock F5, F7, F8, F9, F10 88 $28.71 $3K
Sale Common Stock F6, F7, F8, F9, F10 45,533 $28.71 $1.31M
Holdings After Transaction: Common Stock — 13,164,573 shares (Indirect, By Amberjack Capital Fund II, L.P.); Common Stock — 3,073,822 shares (Indirect, By Innovex Co-Invest Fund II, L.P.); Common Stock — 728,498 shares (Indirect, By Innovex Co-Invest Fund, L.P.); Common Stock — 628,411 shares (Indirect, By Intervale Capital Fund II, L.P.); Common Stock — 311 shares (Indirect, By Intervale Capital Fund II-A, L.P.); Common Stock — 161,707 shares (Indirect, By Intervale Capital Fund III, L.P.)
Footnotes (10)
  1. F1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to Barclays Capital Inc. (the "Underwriter") of $28.71 per share.
  2. F2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  3. F3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  4. F4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share
  5. F5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  6. F6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
  7. F7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
  8. F8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
  9. F9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
  10. F10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Net shares sold 4,954,467 shares Aggregate net sell shares reported across all transactions on 2026-08-10
Offering price $28.71 per share Price to Barclays Capital Inc. in the underwritten secondary offering
Amberjack Capital Fund II post-transaction holding 13,164,573 shares Common stock held indirectly following its reported sale on 2026-08-10
Innovex Co-Invest Fund II post-transaction holding 3,073,822 shares Common stock held indirectly following its reported sale on 2026-08-10
Innovex Co-Invest Fund, L.P. shares sold 205,126 shares Sale at $28.71 per share in the underwritten secondary offering
Intervale Capital Fund III, L.P. acquired shares 45,533 shares Reported as acquired at $28.71 per share on 2026-08-10
underwritten secondary offering financial
"shares of common stock ... were sold in an underwritten secondary offering"
An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.
beneficial owner financial
"therefore may be deemed to be the beneficial owner of such shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
voting and dispositive power financial
"control all voting and dispositive power over the reported shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions were reported for INVX on 2026-08-10?
On 2026-08-10, affiliated funds of Amberjack and Intervale reported net sales of 4,954,467 Innovex (INVX) shares at $28.71 per share in an underwritten secondary offering, alongside one reported acquisition of 45,533 shares.

What price did the INVX shares trade at in the reported insider transactions?
All reported Innovex (INVX) transactions occurred at $28.71 per share. The footnotes state the shares were sold in an underwritten secondary offering at a price to Barclays Capital Inc., which acted as the underwriter.

How many INVX shares did the insiders collectively sell in this Form 4?
Affiliated funds reported an aggregate sale of 4,954,467 Innovex (INVX) shares. This total comes from five sale transactions reported across multiple Amberjack- and Intervale-associated limited partnerships participating in the underwritten secondary offering.

Which entities associated with INVX insiders were involved in the share sales?
Entities include Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund II, L.P., Innovex Co-Invest Fund, L.P., Intervale Capital Fund II, L.P., and Intervale Capital Fund II-A, L.P., all selling shares in the offering at $28.71 per share.

Were any INVX insider holdings reported after these transactions?
Yes. After the trades, Amberjack Capital Fund II, L.P. held 13,164,573 shares of Innovex (INVX), while Innovex Co-Invest Fund II, L.P. held 3,073,822 shares, both as indirect holdings through their partnership structures.

Was the INVX Form 4 filed under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed (box unchecked). The footnotes describe the transactions as part of an underwritten secondary offering, not as trades pursuant to a pre-arranged 10b5-1 plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
INNOVEX CO-INVEST FUND, L.P.
(Last)(First)(Middle)
1021 MAIN STREET,
SUITE 1100
(Street)
HOUSTON TEXAS 77002
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026S3,706,801D$28.71(1)(7)(8)(9)(10)13,164,573IBy Amberjack Capital Fund II, L.P.
Common Stock08/10/2026S865,508D$28.71(2)(7)(8)(9)(10)3,073,822IBy Innovex Co-Invest Fund II, L.P.
Common Stock08/10/2026S205,126D$28.71(3)(7)(8)(9)(10)728,498IBy Innovex Co-Invest Fund, L.P.
Common Stock08/10/2026S176,944D$28.71(4)(7)(8)(9)(10)628,411IBy Intervale Capital Fund II, L.P.
Common Stock08/10/2026S88D$28.71(5)(7)(8)(9)(10)311IBy Intervale Capital Fund II-A, L.P.
Common Stock08/10/2026S45,533A$28.71(6)(7)(8)(9)(10)161,707IBy Intervale Capital Fund III, L.P.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
INNOVEX CO-INVEST FUND, L.P.
(Last)(First)(Middle)
1021 MAIN STREET,
SUITE 1100
(Street)
HOUSTON TEXAS 77002
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Innovex Co-Invest Fund GP, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Interval Capital Associates II, LLC
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Intervale Capital Associates III, LLC
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Intervale Capital Fund II, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUIITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Intervale Capital Fund II-A, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Intervale Capital Fund III, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Intervale Capital GP II, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Intervale Capital GP III, L.P.
(Last)(First)(Middle)
4400 POST OAK PARKWAY,
SUITE 2760
(Street)
HOUSTON TEXAS 77027
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to Barclays Capital Inc. (the "Underwriter") of $28.71 per share.
2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share
5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Remarks:
This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The first of two Forms 4 was filed by the designated filer Amberjack Capital Partners, L.P.
INNOVEX CO-INVEST FUND, L.P., By: Innovex Co-Invest Fund GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INNOVEX CO-INVEST FUND GP, L.P., By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL ASSOCIATES II, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL ASSOCIATES III, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL FUND II, L.P., By: Intervale Capital GP II, L.P., its general partner, By: Intervale Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL FUND II-A, L.P., By Intervale Capital GP II, L.P., its general partner, By: Intervale Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL FUND III, L.P., By: Intervale Capital GP III, L.P., its general partner, By: Intervale Capital Associates III, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL GP II, L.P., By: Intervale Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
INTERVALE CAPITAL GP III, L.P., By: Intervale Capital Associates III, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR